JIR
GHDX

James Investment Research’s Genomic Health, Inc. GHDX Stock Holding History

James Investment Research’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,560
Closed -$1.3M – 839
2019
Q1 		$1.3M Sell
18,560
-5,085
-22% -$377K 0.08% 175
2018
Q4 		$1.52M Sell
23,645
-6,845
-22% -$480K 0.09% 183
2018
Q3 		$2.14M Buy
+30,490
New +$1.78M 0.09% 315

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

James Investment Research's GHDX Position: Q2 2019 in Review

James Investment Research sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 18,560 shares — an estimated $1.3M sold.

James Investment Research first reported a position in GHDX in Q3 2018 and held it in 3 quarters. The position peaked at $2.14M in Q3 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • James Investment Research reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • James Investment Research sold 18,560 Genomic Health, Inc. shares in Q2 2019, an estimated $1.3M.
  • James Investment Research first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 3 quarters.
  • James Investment Research's Genomic Health, Inc. position peaked at $2.14M in Q3 2018.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on James Investment Research's 13F filing for Q2 2019, filed 24 Jul 2019.